There is growing evidence that anti-angiogenic treatments can transiently normalizes tumor vessels, The therapeutic effect is transitory and is ultimately followed by active tumor angiogenesis as tumors rapidly adapt to the effects of anti-VEGF agents and induces refractoriness70, 71. This evidence concerns the gene VEGFA and neoplasm.